HIV seropositive in pregnant South African women who initially refuse routine antenatal HIV screening
- 12 January 2005
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 112 (3) , 370-371
- https://doi.org/10.1111/j.1471-0528.2004.00424.x
Abstract
This study was instituted primarily to determine the HIV seroprevalence of pregnant South African women who refused routine HIV testing at the antenatal clinic of the Johannesburg Hospital, South Africa. Fifty such patients were identified, who, after being fully counselled and informed, agreed to participate in the study, provided total anonymity was adhered to: they did not want to know their results, irrespective of outcome. Blood specimens were given a laboratory reference number only, with no other reference to the patient and analysed utilising the ELISA immunoassay. Twenty‐two of the 50 blood specimens, or 44% of patients analysed, tested positive for HIV. This is an alarming statistic, as the HIV prevalence in the general antenatal population at the Johannesburg Hospital is 29.4%.Keywords
This publication has 4 references indexed in Scilit:
- What can we do to reduce mother to child transmission of HIV?BMJ, 2002
- Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trialThe Lancet, 1999
- Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trialThe Lancet, 1999
- Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine TreatmentNew England Journal of Medicine, 1994